AAAAAA

   
Results: 1-25 | 26-30
Results: 1-25/30
Purified autologous grafting in childhood acute lymphoblastic leukemia in second remission: evidence for long-term clinical and molecular remissions
Authors: Balduzzi, A Gaipa, G Bonanomi, S Dassi, M Perseghin, P Buscemi, F D'Aniello, E Rovelli, A Schiro, R Longoni, D Rambaldi, A Uderzo, C Biondi, A
Citation: A. Balduzzi et al., Purified autologous grafting in childhood acute lymphoblastic leukemia in second remission: evidence for long-term clinical and molecular remissions, LEUKEMIA, 15(1), 2001, pp. 50-56
Anti-CD20 antibody (rituximab) administration in patients with late-occurring lymphomas after solid organ transplant
Authors: Dotti, G Rambaldi, A Fiocchi, R Motta, T Torre, G Viero, P Gridelli, B Barbui, T
Citation: G. Dotti et al., Anti-CD20 antibody (rituximab) administration in patients with late-occurring lymphomas after solid organ transplant, HAEMATOLOG, 86(6), 2001, pp. 618-623
Pharmacokinetic study of the new cyclosporin-A formulation (Neoral (TM)) in adult allogeneic bone marrow transplant recipients
Authors: Dotti, G Gaspari, F Caruso, R Perico, N Remuzzi, G Barbui, T Rambaldi, A
Citation: G. Dotti et al., Pharmacokinetic study of the new cyclosporin-A formulation (Neoral (TM)) in adult allogeneic bone marrow transplant recipients, HAEMATOLOG, 86(3), 2001, pp. 311-315
Meta-analysis of propylthiouracil for alcoholic liver disease - a CochraneHepato-Biliary Group Review
Authors: Rambaldi, A Gluud, C
Citation: A. Rambaldi et C. Gluud, Meta-analysis of propylthiouracil for alcoholic liver disease - a CochraneHepato-Biliary Group Review, LIVER, 21(6), 2001, pp. 398-404
Colchicine for alcoholic and non-alcoholic liver fibrosis or cirrhosis
Authors: Rambaldi, A Gluud, C
Citation: A. Rambaldi et C. Gluud, Colchicine for alcoholic and non-alcoholic liver fibrosis or cirrhosis, LIVER, 21(2), 2001, pp. 129-136
Synergism between fludarabine and rituximab revealed in a follicular lymphoma cell line resistant to the, cytotoxic activity of either drug alone
Authors: Di Gaetano, N Xiao, Y Erba, E Bassan, R Rambaldi, A Golay, J Introna, M
Citation: N. Di Gaetano et al., Synergism between fludarabine and rituximab revealed in a follicular lymphoma cell line resistant to the, cytotoxic activity of either drug alone, BR J HAEM, 114(4), 2001, pp. 800-809
Intensification of salvage treatment with high-dose sequential chemotherapy improves the outcome of patients with refractory or relapsed aggressive non-Hodgkin's lymphoma
Authors: Cortelazzo, S Rambaldi, A Rossi, A Oldani, E Ghielmin, M Benedetti, F Tarella, C Zaglio, F Vitolo, U Di Nicola, M Pogliani, E Cavalli, F Gianni, AM Barbui, T
Citation: S. Cortelazzo et al., Intensification of salvage treatment with high-dose sequential chemotherapy improves the outcome of patients with refractory or relapsed aggressive non-Hodgkin's lymphoma, BR J HAEM, 114(2), 2001, pp. 333-341
CD20 levels determine the in vitro susceptibility to rituximab and complement of B-cell chronic lymphocytic leukemia: further regulation by CD55 and CD59
Authors: Golay, J Lazzari, M Facchinetti, V Bernasconi, S Borleri, G Barbui, T Rambaldi, A Introna, M
Citation: J. Golay et al., CD20 levels determine the in vitro susceptibility to rituximab and complement of B-cell chronic lymphocytic leukemia: further regulation by CD55 and CD59, BLOOD, 98(12), 2001, pp. 3383-3389
Tyrosine kinase inhibitor ST1571 potentiates the pharmacologic activity ofretinoic acid in acute promyelocytic leukemia cells: effects on the degradation of RAR alpha and PML-RAR alpha
Authors: Gianni', M Kalac, Y Ponzanelli, I Rambaldi, A Terao, M Garattini, E
Citation: M. Gianni' et al., Tyrosine kinase inhibitor ST1571 potentiates the pharmacologic activity ofretinoic acid in acute promyelocytic leukemia cells: effects on the degradation of RAR alpha and PML-RAR alpha, BLOOD, 97(10), 2001, pp. 3234-3243
Preliminary results of a risk-oriented program for B-lineage adult acute lymphoblastic leukemia (ALL): The collaborative Italian study 08/96
Authors: Bassan, R Rambaldi, A Pogliani, E Rossi, G Fabris, P Morandi, S Casula, P Lambertenghi-Deliliers, G Vespignani, M Lerede, T Personeni, A Bellavita, P Barbui, T
Citation: R. Bassan et al., Preliminary results of a risk-oriented program for B-lineage adult acute lymphoblastic leukemia (ALL): The collaborative Italian study 08/96, HEMAT BLOOD, 40, 2001, pp. 419-425
Prognostic factors in Philadelphia plus BCR-ABL plus acute lymphoblastic leukemia
Authors: Bassan, R Rohatiner, AZ Di Bona, E Lerede, T Carter, M Rambaldi, A Pogliani, E Rossi, G Fabris, P Morandi, S Lambertenghi-Deliliers, G Lister, TA Barbui, T
Citation: R. Bassan et al., Prognostic factors in Philadelphia plus BCR-ABL plus acute lymphoblastic leukemia, HEMAT BLOOD, 40, 2001, pp. 426-431
Retinoid-dependent growth inhibition, differentiation and apoptosis in acute promyelocytic leukemia cells. Expression and activation of caspases
Authors: Gianni, M Ponzanelli, I Mologni, L Reichert, U Rambaldi, A Terao, M Garattini, E
Citation: M. Gianni et al., Retinoid-dependent growth inhibition, differentiation and apoptosis in acute promyelocytic leukemia cells. Expression and activation of caspases, CELL DEAT D, 7(5), 2000, pp. 447-460
Genetic modification of human T cells with CD20: A strategy to purify and lyse transduced cells with anti-CD20 antibodies
Authors: Introna, M Barbui, AM Bambacioni, F Casati, C Gaipa, G Borleri, G Bernasconi, S Barbui, T Golay, J Biondi, A Rambaldi, A
Citation: M. Introna et al., Genetic modification of human T cells with CD20: A strategy to purify and lyse transduced cells with anti-CD20 antibodies, HUM GENE TH, 11(4), 2000, pp. 611-620
Molecular profile of Epstein-Barr virus infection in HHV-8-positive primary effusion lymphoma
Authors: Fassone, L Bhatia, K Gutierrez, M Capello, D Gloghini, A Dolcetti, R Vivenza, D Ascoli, V Lo Coco, F Pagani, L Dotti, G Rambaldi, A Raphael, M Tirelli, U Saglio, G Magrath, IT Carbone, A Gaidano, G
Citation: L. Fassone et al., Molecular profile of Epstein-Barr virus infection in HHV-8-positive primary effusion lymphoma, LEUKEMIA, 14(2), 2000, pp. 271-277
Need for an accurate molecular diagnosis to assess the donor origin of leukemia relapse after allogeneic stem cell transplantation
Authors: Spinelli, O Giussani, U Borleri, G Lazzari, M Michelato, A Dotti, G Barbui, T Rambaldi, A
Citation: O. Spinelli et al., Need for an accurate molecular diagnosis to assess the donor origin of leukemia relapse after allogeneic stem cell transplantation, HAEMATOLOG, 85(11), 2000, pp. 1153-1157
Mild hypothermia delays the onset of coma and prevents brain edema and extracellular brain glutamate accumulation in rats with acute liver failure
Authors: Rose, C Michalak, A Pannunzio, M Chatauret, N Rambaldi, A Butterworth, RF
Citation: C. Rose et al., Mild hypothermia delays the onset of coma and prevents brain edema and extracellular brain glutamate accumulation in rats with acute liver failure, HEPATOLOGY, 31(4), 2000, pp. 872-877
Cochrane Hepato-Biliary Group Protocol - Colchicine for alcoholic and non-alcoholic liver fibrosis and cirrhosis
Authors: Rambaldi, A Gluud, C
Citation: A. Rambaldi et C. Gluud, Cochrane Hepato-Biliary Group Protocol - Colchicine for alcoholic and non-alcoholic liver fibrosis and cirrhosis, LIVER, 20(3), 2000, pp. 262-266
Epstein-Barr virus-negative lymphoproliferative disorders in long-term survivors after heart, kidney, and liver transplant
Authors: Dotti, G Fiocchi, R Motta, T Gamba, A Gotti, E Gridelli, B Borleri, G Manzoni, C Viero, P Remuzzi, G Barbui, T Rambaldi, A
Citation: G. Dotti et al., Epstein-Barr virus-negative lymphoproliferative disorders in long-term survivors after heart, kidney, and liver transplant, TRANSPLANT, 69(5), 2000, pp. 827-833
Isolation and characterization of an acute promyelocytic leukemia cell line selectively resistant to the novel antileukemic and apoptogenic retinoid 6-[3-adamantyl-4-hydroxyphenyl]-2-naphthalene carboxylic acid
Authors: Ponzanelli, I Gianni, M Giavazzi, R Garofalo, A Nicoletti, I Reichert, U Erba, E Rambaldi, A Terao, M Garattini, E
Citation: I. Ponzanelli et al., Isolation and characterization of an acute promyelocytic leukemia cell line selectively resistant to the novel antileukemic and apoptogenic retinoid 6-[3-adamantyl-4-hydroxyphenyl]-2-naphthalene carboxylic acid, BLOOD, 95(8), 2000, pp. 2672-2682
Biologic response of B lymphoma cells to anti-CD20 monoclonal antibody rituximab in vitro: CD55 and CD59 regulate complement-mediated cell lysis
Authors: Golay, J Zaffaroni, L Vaccari, T Lazzari, M Borleri, GM Bernasconi, S Tedesco, F Rambaldi, A Introna, M
Citation: J. Golay et al., Biologic response of B lymphoma cells to anti-CD20 monoclonal antibody rituximab in vitro: CD55 and CD59 regulate complement-mediated cell lysis, BLOOD, 95(12), 2000, pp. 3900-3908
Characterization of the human myeloid leukemia-derived cell line GF-D8 by multiplex fluorescence in situ hybridization, subtelomeric probes, and comparative genomic hybridization
Authors: Tosi, S Giudici, G Rambaldi, A Scherer, SW Bray-Ward, P Dirscherl, L Biondi, A Kearney, L
Citation: S. Tosi et al., Characterization of the human myeloid leukemia-derived cell line GF-D8 by multiplex fluorescence in situ hybridization, subtelomeric probes, and comparative genomic hybridization, GENE CHROM, 24(3), 1999, pp. 213-221
Clinical outcome after autologous transplantation in non-Hodgkin's lymphoma patients with high international prognostic index (IPI)
Authors: Cortelazzo, S Rossi, A Bellavita, P Oldani, E Viero, P Buelli, M Rambaldi, A Barbui, T
Citation: S. Cortelazzo et al., Clinical outcome after autologous transplantation in non-Hodgkin's lymphoma patients with high international prognostic index (IPI), ANN ONCOL, 10(4), 1999, pp. 427-432
Primary effusion lymphoma after heart transplantation: a new entity associated with human herpesvirus-8
Authors: Dotti, G Fiocchi, R Motta, T Facchinetti, B Chiodini, B Borleri, GM Gavazzeni, G Barbui, T Rambaldi, A
Citation: G. Dotti et al., Primary effusion lymphoma after heart transplantation: a new entity associated with human herpesvirus-8, LEUKEMIA, 13(5), 1999, pp. 664-670
Standardized RT-PCR analysis of fusion gene transcripts from chromosome aberrations in acute leukemia for detection of minimal residual disease - Report of the BIOMED-1 Concerted Action: Investigation of minimal residual disease in acute leukemia
Authors: van Dongen, JJM Macintyre, EA Gabert, JA Delabesse, E Rossi, V Saglio, G Gottardi, E Rambaldi, A Dotti, G Griesinger, F Parreira, A Gameiro, P Diaz, MG Malec, M Langerak, AW San Miguel, JF Biondi, A
Citation: Jjm. Van Dongen et al., Standardized RT-PCR analysis of fusion gene transcripts from chromosome aberrations in acute leukemia for detection of minimal residual disease - Report of the BIOMED-1 Concerted Action: Investigation of minimal residual disease in acute leukemia, LEUKEMIA, 13(12), 1999, pp. 1901-1928
The effects of the level of ampicillin resistance and the inoculum size onthe in-vitro bactericidal activity of the combination of ampicillin and ciprofloxacin against high-level gentamicin-resistant strains of Enterococcusfaecium
Authors: Tripodi, MF Rambaldi, A Sarnataro, G Ragone, E Utili, R
Citation: Mf. Tripodi et al., The effects of the level of ampicillin resistance and the inoculum size onthe in-vitro bactericidal activity of the combination of ampicillin and ciprofloxacin against high-level gentamicin-resistant strains of Enterococcusfaecium, J ANTIMICRO, 44(5), 1999, pp. 719-720
Risultati: 1-25 | 26-30